OKAMOTO TOMOYOSHI | Department of Surgery, Jikei University School of Medicine
スポンサーリンク
概要
関連著者
-
Kita Yoshiaki
Department Of Surgery Jikei University School Of Medicine
-
Yanaga Katsuhiko
Department Of Surgery The Jikei University School Of Medicine
-
Yanaga Katsuhiko
Department Of Surgery Aoto Hospital Jikei University School Of Medicine
-
FUJIOKA Shuichi
Department of Surgery, Jikei University School of Medicine
-
Fujioka Shuichi
Department Of Surgery Jikei University School Of Medicine
-
OKAMOTO TOMOYOSHI
Department of Surgery, Jikei University School of Medicine
-
Okamoto Tomoyoshi
Department Of Surgery Jikei University School Of Medicine
-
YANAGA Katsuhiko
Department of Transplantation and Digestive Surgery, Nagasaki University Graduate School of Biomedic
-
ISHIDA Yuichi
Department of Oral & Maxillofacial Prosthodontics and Oral Implantology, The University of Tokushima
-
Ishida Yuichi
Department Of Surgery Jikei University School Of Medicine
-
Misawa Takeyuki
Department of Surgery, The Jikei University School of Medicine
-
Yanaga Katsuhiko
Department Of Surgery Jikei University School Of Medicine
-
SHIDA Atsuo
Department of Surgery, Jikei University School of Medicine
-
Shida Atsuo
Department Of Surgery Jikei University School Of Medicine
-
GOCHO Takeshi
Department of Surgery, Jikei University School of Medicine
-
FUTAGAWA YASURO
Department of Surgery, Jikei University School of Medicine
-
Futagawa Yasuro
Department Of Surgery Jikei University School Of Medicine
-
Gocho Takeshi
Department Of Surgery Jikei University School Of Medicine
-
Misawa Takeyuki
Department Of Surgery Jikei University School Of Medicine
-
FUJITA Akihiko
Department of Surgery, Jikei University School of Medicine
-
KURIHARA Hideaki
Department of Surgery, Jikei University School of Medicine
-
Fujita Akihiko
Department Of Surgery Jikei University School Of Medicine
-
Kurihara Hideaki
Department Of Surgery Jikei University School Of Medicine
著作論文
- Preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the evaluation of curability and resectability in patients with pancreatic adenocarcinoma
- Clinical significance of Rho GDP dissociation inhibitor 2 in colorectal carcinoma